Lymphoedema management in podoconiosis - Authors reply
We thank Jill Brooks and colleagues for their comments on how their trial was referred to in our article.
Autors principals: | Molla, M, Ngari, M, Berkley, J, Njuguna, P, Fegan, G, Lang, T, Newport, M, Enquoselassie, F, Davey, G, Golbet Team |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Elsevier
2018
|
Ítems similars
-
Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis in northern Ethiopia (GoLBeT): a pragmatic randomised controlled trial
per: Negussie, H, et al.
Publicat: (2018) -
Cost-effectiveness of podoconiosis lymphoedema treatment in northern Ethiopia: Results from the goblet trial
per: Clarke, A, et al.
Publicat: (2018) -
Cost-effectiveness and social outcomes of a community-based treatment for podoconiosis lymphoedema in the East Gojjam zone, Ethiopia.
per: Natalia Hounsome, et al.
Publicat: (2019-10-01) -
Lymphoedema management to prevent acute dermatolymphangioadenitis in podoconiosis in northern Ethiopia (GoLBeT): a pragmatic randomised controlled trial
per: Henok Negussie, PhD, et al.
Publicat: (2018-07-01) -
Excess mortality among people with podoconiosis: secondary analysis of two Ethiopian cohorts
per: Masraf, H, et al.
Publicat: (2020)